Back
AbbVie Vs. Eli Lilly and Industry Stock Comparison
Buy
55
ABBV
AbbVie
Last Price:
160.50
Seasonality Move:
1.92%
Buy
68
LLY
Eli Lilly and
Last Price:
758.17
Seasonality Move:
3.51%
Buy
55
AbbVie (ABBV)
is a Buy
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $161.72. The Score for ABBV is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ABBV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $776.75. The Score for LLY is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- LLY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $776.75
The current trend is moderately bullish and LLY is experiencing slight buying pressure.
ABBV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.11 | Sell |
Relative Strength Index (14 RSI): | 37.26 | Sell |
Chaikin Money Flow: | -2822567 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (162.05 - 175.19) | Sell |
Bollinger Bands (100): | (158.9 - 177.42) | Sell |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.08 | Sell |
Relative Strength Index (14 RSI): | 59.1 | Buy |
Chaikin Money Flow: | 508971 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (737.86 - 774.12) | Buy |
Bollinger Bands (100): | (625.23 - 775.61) | Buy |
ABBV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 164.75 | Sell |
20-day SMA: | 165.71 | Sell |
50-day SMA: | 173.61 | Sell |
200-day SMA: | 157.22 | Buy |
8-day EMA: | 163.64 | Sell |
20-day EMA: | 166.61 | Sell |
50-day EMA: | 169.41 | Sell |
200-day EMA: | 160.76 | Buy |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 745.33 | Buy |
20-day SMA: | 752.16 | Buy |
50-day SMA: | 761.33 | Buy |
200-day SMA: | 627.43 | Buy |
8-day EMA: | 753.46 | Buy |
20-day EMA: | 752.21 | Buy |
50-day EMA: | 743.88 | Buy |
200-day EMA: | 636.45 | Buy |
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.20 per share, an increase this year of $0.09 per share, and an increase next year of $0.84 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.94 per share, a decrease next quarter of $0.33 per share, an increase this year of $7.55 per share, and an increase next year of $4.84 per share.
AbbVie Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |